These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6684457)

  • 1. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1026-9. PubMed ID: 6684457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
    Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: On the action of oxotremorine on the cholinergic system of rat brain.
    Pleul O
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R75. PubMed ID: 4276628
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of oral CDP-choline on acrylamide-induced lesion.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1029-33. PubMed ID: 6684458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the protection of CDP-choline against nicotine intoxication.
    Grau T; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1025-6. PubMed ID: 6684456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the effects of oral administration of CDP-choline on EEG changes and lethality induced by epidural compression in the anaesthetised cat.
    Algate DR; Beard DJ; Sacristán A; Ortiz JA; Davies JE
    Arzneimittelforschung; 1983; 33(7A):1013-6. PubMed ID: 6684452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interaction of drugs with the cholinergic nervous system--IV. Tolerance to oxotremorine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1977 Sep; 26(18):1681-7. PubMed ID: 901587
    [No Abstract]   [Full Text] [Related]  

  • 9. CDP-choline: acute toxicity study.
    Grau T; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1033-4. PubMed ID: 6684459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system.
    Cansev M; Yilmaz MS; Ilcol YO; Hamurtekin E; Ulus IH
    Eur J Pharmacol; 2007 Dec; 577(1-3):129-42. PubMed ID: 17884041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1016-8. PubMed ID: 6684453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic adaptations to chronic oxotremorine infusion.
    Marks MJ; Artman LD; Patinkin DM; Collins AC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):337-43. PubMed ID: 7252834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioactivity incorporation into different cerebral phospholipids after oral administration of 14C methyl CDP-choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1048-50. PubMed ID: 6684464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of subacute toxicity of CDP-choline after 30 days of oral administration to rats.
    Romero A; Grau T; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1035-8. PubMed ID: 6684460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytidine diphosphate choline (citicoline, Somazina).
    Arzneimittelforschung; 1983; 33(7A):1011-80. PubMed ID: 6684451
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
    Lozano Fernández R
    Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDP-choline: 6-month study on toxicity in dogs.
    Romero A; Grau T; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1038-42. PubMed ID: 6684461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of methyl-14C CDP-choline by oral route.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1045-7. PubMed ID: 6684463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J; Ganoza C
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.